Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012930Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 22 enero 2018see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vías respiratorias
- Copyright:
-
- Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Dr Ho, Dr Maqsood and Dr Evans updated and wrote the background section.
All authors contributed to the development of the protocol. See acknowledgement statement.
Sources of support
Internal sources
-
Lancaster University, UK.
David Evans received support in the form of a salary.
External sources
-
No sources of support supplied
Declarations of interest
U Maqsood: none.
D Evans: provides freelance writing support to medical communications agencies.
T Ho: none.
K Palmer: none.
F Eccles: none.
M Munavvar: none.
I Crossingham: none.
Acknowledgements
We gratefully acknowledge Dr Emma Dennett for her role in refining our research question, and Ms. Elizabeth Stovold for developing the search strategy.
The Background and Methods section of this protocol are based on a standard template used by Cochrane Airways Group. Some of the content from an earlier Cochrane protocol has been used verbatim and modified after the original author team stepped down from the review (Sarai 2014).
This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. Dr Evans's post is funded by the Faculty of Health and Medicine, Lancaster University. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.
Version history
| Published | Title | Stage | Authors | Version |
| 2019 Mar 06 | Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease | Review | Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham, David JW Evans | |
| 2018 Jan 22 | Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease | Protocol | Usman Maqsood, David JW Evans, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Iain Crossingham | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
- Adrenergic beta-2 Receptor Agonists [*administration & dosage, adverse effects];
- Cause of Death;
- Cross-Over Studies;
- Disease Progression;
- Drug Administration Schedule;
- Drug Combinations;
- Muscarinic Antagonists [*administration & dosage, adverse effects];
- Nebulizers and Vaporizers;
- Placebos [administration & dosage];
- Pulmonary Disease, Chronic Obstructive [*drug therapy, mortality];
- Quality of Life;
- Randomized Controlled Trials as Topic;
Medical Subject Headings Check Words
Aged; Humans; Middle Aged;
